Predicting the clinical efficacy of antibiotics: Toward definitive criteria

Pediatric Infectious Disease Journal

Volumn 16, Issue 3 SUPPL., 1997, Pages

  Scaglione, Francesco ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

antibiotics; Clinical efficacy; pharmacokinetics

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFIXIME; CEFTIBUTEN; CEPHALOSPORIN DERIVATIVE; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

BACTERICIDAL ACTIVITY; CONFERENCE PAPER; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG PENETRATION; DRUG PROTEIN BINDING; INFECTION; INTERSTITIAL FLUID; MIDDLE EAR; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CEPHALOSPORINS; EAR, MIDDLE; HUMANS; MACROLIDES; MICROBIAL SENSITIVITY TESTS;

EID: 0030893489     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199703001-00006     Document Type: Conference Paper

References (31)

1. Drusano GL. Role of pharmacokinetics in outcome of infections. Antimicrob Agents Chemother 1988;32:289-97.
2. Ryan DM, Cars O, Hoffstedt B. The use of antibiotic serum levels to predict concentrations in tissues. Scand J Infect Dis 1986;18:381-8.
3. Schentag JJ. Clinical significance of antibiotic tissue penetration. Clin Pharmacokinet 1989;16(Suppl 1):25-31.
4. Carbon C, Contrepois A, Brion N, Lamotte-Barrilton S. Penetration of cefazolin, cephaloridine, and cefamandole into interstitial fluid in rabbits. Antimicrob Agents Chemother 1977;11:594-8.
5. Schafer-Korting M, Korting HC, Maas L, et al. Cefodizime penetration into skin suction blister fluid following intravenous dose. Eur J Clin Pharmacol 1986;30:295-8.
6. Tan JS, Salstrom SJ. Levels of carbenicillin, ticarcillin, cephalotin, cefazolin, cefamandole, gentamicin, tobramycin, and amikacin in human serum and interstitial fluid. Antimicrob Agents Chemother 1977;11:698-700.
7. LeBel M, Gregore S, Caron M, Bergeron MG. Difference in blister fluid penetration after single and multiple doses of ceftriaxone. Antimicrob Agents Chemother 1985;28:123-7.
8. Tan JS, Salstrom SJ, Signs SA, Hollman HE, File TM. Pharmacokinetics of intravenous cefmetazole with emphasis on comparison between predicted theoretical levels in tissue and actual skin window fluid levels. Antimicrob Agents Chemother 1989;33:924-7.
9. Yuk JH, Nightingale GH, Quintiliani R. Clinical pharmacokinetics of ceftriaxone. Clin Pharmacokinet 1989;17:223-35.
10. Fraschini F, Scaglione F, Pintucci G, et al. The diffusion of clarithromycin and roxithromycin into nasal mucosa, tonsil and lung in humans. J Antimicrob Chemother 1991;27(Suppl A):61-5.
11. Johnson JD, Hand WL, Francis JR, et al. Antibiotic uptake by alveolar macrophages. J Lab Clin Med 1980;95:429-39.
12. Martin JR, Johnson P, Miller MF. Uptake, accumulation and egress of erythromycin by tissue culture cells of human origin. Antimicrob Agents Chemother 1985;27:314-9.
13. Chisholm GD, Smith CB, Waterworth PM, Canan JS. Factors influencing the distribution of antibacterial agents in interstitial tissue fluid: molecular size and protein binding. Infection 1976;4(Suppl):S123-7.
14. Craig WA, Suh B. Theory and practical impact of binding of antimicrobials to serum proteins and tissue. Scan J Infect Dis 1978;Suppl 14:92-9.
15. Deguchi Y, Nakashima E, Ishikawa F, et al. Peritoneal transport of beta-lactam antibiotics: effects of plasma protein binding and the interspecies relationship. J Pharm Sci 1988; 77:559-64.
16. Deguchi Y, Terasaki T, Yamada H, Tsuji A. An application of microdialysis to drug tissue distribution study: in vivo evidence for free-ligand hypothesis and tissue binding of beta-lactam antibiotics in interstitial fluids. J Pharmacobiodyn 1992;15:78-89.
17. Bergan T, Engeset A, Olzewski W, et al. Extravascular penetration of highly protein bound flucloxacillin. Antimicrob Agents Chemother 1986;30:729-32.
18. Cars O, Henning C, Holm SE. Penetration of ampicillin and dicloxacillin into tissue cage fluid in rabbits: relation to serum and tissue binding. Scand J Infect Dis 1981;13:69-74.
19. Gerding DN, Petersen LR. Serum protein binding and extravascular distribution of antimicrobials. J Antimicrob Chemother 1985;15:136-8.
20. Rolinson GN, Sutherland R. The binding of antibiotics to serum proteins. Br J Pharmacol 1965; 25:638-50.
21. Shyu WC, Quintiliani R, Nightingale CH, Dudley MN. Effect of protein binding on drug penetration into blister fluid. Antimicrob Agents Chemother 1988;32:128-30.
22. Wise R, Gillet AP, Cadge B, Durham SR, Baker S. The influence of protein binding upon tissue fluid levels of six beta-lactam antibiotics. J Infect Dis 1980;142:77-82.
23. Craig WA, Kunin CM. Significance of serum protein and tissue binding of antimicrobial agents. Annu Rev Med 1976; 27:287-300.
24. Kunin CM, Craig WA, Korngut M, Monson R. Influence of binding on the pharmacologic activity of antibiotics. Ann NY Acad Sci 1973;226:214-24.
25. Rolinson GN. The significance of protein binding of antibiotics in bacterial chemotherapy. J Antimicrob Chemother 1980; 6:311-7.
26. Gerding DN, Peterson LR, Legeer DC, Hall WH, Schierl EA. Ascitic fluid cephalosporin concentrations: influence of protein binding and serum pharmacokinetics. Antimicrob Agents Chemother 1978;14:234-9.
27. Peterson LR, Gerding DN. Influence of protein binding of antibiotics on serum pharmacokinetics and extravascular penetration: clinically useful concepts. Rev Infect Dis 1980; 2:340-8.
28. Scaglione F, Raichi M, F Fraschini F. Serum protein binding and extravascular diffusion of methoxyimino cephalosporins. J Antimicrob Chemother 1990;26(Suppl A):1-10.
29. Wise R. The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy. Clin Pharmacokinet 1986;11:470-82.
30. Peterson LR, Gerding DN. Prediction of cefazolin penetration into high- and low-protein containing extravascular fluid: new method for performing simultaneous studies. Antimicrob Agents Chemother 1978;14:533-8.
31. Scaglione F, Demartini G, Arcidiacono MM, Pintucci JP. Optimum treatment of streptococcal pharyngitis. Drugs 1997; 53:86-97.